GlassScriptPhysician profile
David Y Mok
NPI 1619061157
$32,641.57
in general payments reported to CMS, 2019-2025
31 companies · $3,619 in 2025
The $3,619 reported for 2025 was more than what a typical Clinical Cardiac Electrophysiology provider received nationally (typical 2025 total: $2,477).
See the full distribution for Clinical Cardiac Electrophysiology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $5,645 · 2020: $3,610 · 2021: $1,677 · 2022: $4,265 · 2023: $5,387 · 2024: $8,440 · 2025: $3,619.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $4,311.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $13,133.98 |
| Travel and Lodging | $4,311.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,843.43 | 2019-2025 | Emblem Mri S-Icd, Farapulse, Bodyguardian |
| Medtronic, INC. | $9,739.83 | 2021-2025 | Micra, Azure Xt Dr Mri Surescan, Onyx Frontier |
| Medtronic Vascular, INC. | $4,421.29 | 2019-2020 | |
| Abbott Laboratories | $3,698.73 | 2020-2025 | Aveir, Triclip, Mitraclip |
| Novartis Pharmaceuticals Corporation | $583.20 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $451.84 | 2019-2021 | |
| Biotronik INC. | $416.80 | 2021-2023 | Acticor 7 Vr-T Dx |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $389.90 | 2019-2025 | Lifevest |
| E.R. Squibb & Sons, L.L.C. | $329.60 | 2019-2025 | Camzyos, Eliquis |
| Cardiva Medical, INC. | $273.47 | 2023-2024 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Amgen INC. | $221.95 | 2019-2024 | Repatha |
| Astrazeneca Pharmaceuticals LP | $174.36 | 2019-2024 | Farxiga, Brilinta |
| Pfizer INC. | $160.80 | 2019-2025 | |
| Alnylam Pharmaceuticals INC. | $150.00 | 2025 | Onpattro |
| Janssen Pharmaceuticals, INC | $145.89 | 2019-2024 | Xarelto |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biosense Webster, INC. | $113.09 | 2019-2024 | Pentaray Nav, Carto 3 |
| Akcea Therapeutics, INC. | $65.84 | 2020 | |
| Braemar Manufacturing, LLC | $55.52 | 2019 | |
| Edwards Lifesciences Corporation | $53.70 | 2019-2020 | |
| Lexicon Pharmaceuticals, INC. | $44.28 | 2023 | Inpefa |
| Boehringer Ingelheim Pharmaceuticals, INC. | $41.73 | 2019 | |
| Heartflow, INC. | $40.87 | 2025 | |
| Irhythm Technologies, INC. | $38.47 | 2024 | Zio Xt Patch, Zio Monitor |
| Bardy Diagnostics, INC. | $30.83 | 2020 | |
| Kiniksa Pharmaceuticals International, Plc | $29.98 | 2024 | Arcalyst |
| Cvrx, INC. | $26.48 | 2024 | Barostim Neo System |
| Baxter Healthcare | $25.00 | 2019 | |
| Amarin Pharma, INC. | $22.70 | 2019 | |
| Ge Healthcare | $22.28 | 2025 | |
| Vertiflex, INC. | $19.36 | 2019 | |
| Biomerieux INC | $10.35 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Mok listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.